DelveInsight’s “Periodontal Inflammation Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Periodontal Inflammation market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Periodontal Inflammation market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Periodontal Inflammation: An Overview
Periodontal diseases are mainly the result of infections and inflammation of the gums and bones that surround and support the teeth. In its early stage, called gingivitis, the gums can become swollen and red, and they may bleed. In its more serious form, called periodontitis, the gums can pull away from the tooth, bone can be lost, and the teeth may loosen or even fall out.
Chronic and progressive periodontal disease is characterized by unresolved inflammation, fibrosis, and loss of tissue structure and function. There are many forms of periodontitis. The most common ones include aggressive periodontitis, chronicperiodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal disease.
Periodontal Inflammation Market Key Facts
According to the CDC, 47.2% of adults aged 30 years and older have some form of periodontal disease. Periodontal disease increases with age; 70.1% of adults 65 years and older have periodontal disease. Moreover, this condition is more common in men than women (56.4% vs. 38.4%) and current smokers (64.2%).
As per World Health Organization (WHO), severe periodontal (gum) disease is found in 5–20% of middle-aged (35–44 years) adults in Europe and up to 40% of older people (65–74 years).
Periodontal Inflammation Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Periodontal Inflammation market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Periodontal Inflammation market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.
Periodontal Inflammation Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders.
The Report Covers the Periodontal Inflammation Epidemiology Segmentation by –
Severity-specific Prevalent Population of Periodontal Disease
Age-specific Prevalent Population of Periodontal Disease
Prevalent Population of Periodontal Disease
Diagnosed and Treatable Cases of Periodontal Disease
Gender-specific Prevalent Population of Periodontal Disease
Periodontal Inflammation Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Periodontal Inflammation market or expected to get launched during the study period. The analysis covers the Periodontal Inflammation market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Periodontal Inflammation Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How Periodontal Inflammation Market Will Evolve by 2032 @
Some of the key companies in the Periodontal Inflammation Market include:
Periodontal Inflammation Therapies covered in the report include:
And many more
The pipeline of Periodontal Disease is very bleak, with few potential key players. This showcases an unmet need for non-surgical therapies involving drugs for treating the condition. However, this scenario is expected to get better in the coming years.
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More @
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Periodontal Inflammation Competitive Intelligence Analysis
4. Periodontal Inflammation Market Overview at a Glance
5. Periodontal Inflammation Disease Background and Overview
6. Periodontal Inflammation Patient Journey
7. Periodontal Inflammation Epidemiology and Patient Population (In the US, EU5, and Japan)
8. Periodontal Inflammation Treatment Algorithm, Current Treatment, and Medical Practices
9. Periodontal Inflammation Unmet Needs
10. Key Endpoints of Periodontal Inflammation Treatment
11. Periodontal Inflammation Marketed Products
12. Periodontal Inflammation Emerging Drugs and Latest Therapeutic Advances
13. Periodontal Inflammation Seven Major Market Analysis
14. Attribute Analysis
15. Periodontal Inflammation Market Outlook (In US, EU5, and Japan)
16. Periodontal Inflammation Access and Reimbursement Overview
17. KOL Views on the Periodontal Inflammation Market
18. Periodontal Inflammation Market Drivers
19. Periodontal Inflammation Market Barriers
21. DelveInsight Capabilities
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report @
Other Trending Healthcare Reports By DelveInsight
Periodontal Inflammation Pipeline Insight, 2022
“Periodontal Inflammation Pipeline Insights, 2022” report by DelveInsight outlays comprehensive insights into the present clinical development scenario and growth prospects across Periodontal Inflammation Market.
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States